What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
Internal medicine, Surgery, Lymphoma, Hodgkin's lymphoma and Chemotherapy are his primary areas of study.
His Internal medicine research includes elements of Gastroenterology and Oncology.
His study looks at the intersection of Surgery and topics like Refractory Hodgkin Lymphoma with DHAP and Autologous stem-cell transplantation.
His study in Lymphoma is interdisciplinary in nature, drawing from both Stage, Progressive disease and Lymphocyte.
The study incorporates disciplines such as Combination chemotherapy, Quality of life and Standard treatment in addition to Hodgkin's lymphoma.
His research on Chemotherapy also deals with topics like
- Survival analysis which connect with Clinical trial and Randomized controlled trial,
- Carmustine most often made with reference to Transplantation.
His most cited work include:
- Revised response criteria for malignant lymphoma (3306 citations)
- A Prognostic Score for Advanced Hodgkin's Disease (1337 citations)
- Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. (1003 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Surgery, Lymphoma, Chemotherapy and Oncology.
Within one scientific family, Volker Diehl focuses on topics pertaining to Gastroenterology under Internal medicine, and may sometimes address concerns connected to Progressive disease.
Volker Diehl usually deals with Lymphoma and limits it to topics linked to Cancer research and Antigen.
Volker Diehl interconnects Disease and Hodgkin lymphoma in the investigation of issues within Oncology.
His ABVD course of study focuses on Dacarbazine and Vinblastine.
His CD30 research includes themes of Molecular biology and Monoclonal antibody.
He most often published in these fields:
- Internal medicine (43.12%)
- Surgery (24.44%)
- Lymphoma (20.65%)
What were the highlights of his more recent work (between 2007-2021)?
- Internal medicine (43.12%)
- Oncology (19.24%)
- Surgery (24.44%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Surgery, ABVD and BEACOPP.
His study in Internal medicine concentrates on Procarbazine, Chemotherapy, Hodgkin lymphoma, Hodgkin's lymphoma and Dacarbazine.
His Chemotherapy research integrates issues from Gastroenterology, Brentuximab vedotin and Dose Reduced.
His studies in Oncology integrate themes in fields like Stage, Hematology, Immunology and Radiation therapy.
His Surgery study combines topics from a wide range of disciplines, such as Standard treatment and Lymphoma.
His work is dedicated to discovering how BEACOPP, Clinical endpoint are connected with Median follow-up and other disciplines.
Between 2007 and 2021, his most popular works were:
- Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. (598 citations)
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial (406 citations)
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study (353 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Volker Diehl focuses on Internal medicine, Surgery, Procarbazine, Hodgkin's lymphoma and Oncology.
His Internal medicine study frequently links to other fields, such as Gastroenterology.
His work on Surgery deals in particular with ABVD, Regimen, Dacarbazine, Chemotherapy and Survival rate.
His study looks at the relationship between Procarbazine and fields such as BEACOPP, as well as how they intersect with chemical problems.
His work carried out in the field of Hodgkin's lymphoma brings together such families of science as Progression-free survival and Standard treatment.
His work in Oncology covers topics such as Hodgkin lymphoma which are related to areas like Combined modality, Translational research, Disease and Advanced disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
